272 related articles for article (PubMed ID: 34158412)
21. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis.
Liu Z; Luo Y; Su L; Hu X
Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the role of Frizzled 2 in different cancer types.
Zhou M; Sun X; Zhu Y
FEBS Open Bio; 2021 Apr; 11(4):1195-1208. PubMed ID: 33565732
[TBL] [Abstract][Full Text] [Related]
23. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
Tang S; Zhuge Y
Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185
[TBL] [Abstract][Full Text] [Related]
24. Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.
Wang Y; Chen L; Yu M; Fang Y; Qian K; Wang G; Ju L; Xiao Y; Wang X
Cancer Med; 2020 Oct; 9(20):7729-7741. PubMed ID: 32841548
[TBL] [Abstract][Full Text] [Related]
25. Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification.
Chen Y; You S; Li J; Zhang Y; Kokaraki G; Epstein E; Carlson J; Huang WK; Haglund F
Front Immunol; 2021; 12():788959. PubMed ID: 35069566
[TBL] [Abstract][Full Text] [Related]
26. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
27. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
[TBL] [Abstract][Full Text] [Related]
28. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
30. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response.
Hu FF; Liu CJ; Liu LL; Zhang Q; Guo AY
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32814346
[TBL] [Abstract][Full Text] [Related]
31. Mismatch repair gene
Zhou LZ; Xiao HQ; Chen J
Front Immunol; 2024; 15():1302797. PubMed ID: 38390329
[TBL] [Abstract][Full Text] [Related]
32. A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer.
Xie Y; Fu R; Xiao Z; Li G
Pathol Oncol Res; 2022; 28():1610030. PubMed ID: 35356506
[TBL] [Abstract][Full Text] [Related]
33. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
[TBL] [Abstract][Full Text] [Related]
34. Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma.
Wang Y; Ren F; Chen P; Liu S; Song Z; Ma X
Cancer Med; 2018 Nov; 7(11):5632-5642. PubMed ID: 30306731
[TBL] [Abstract][Full Text] [Related]
35. A novel risk prediction model of pyroptosis-related genes for the prognosis and immunotherapy response of endometrial cancer.
Liu ZS; Jing CL
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2259-2278. PubMed ID: 35442481
[TBL] [Abstract][Full Text] [Related]
36. BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.
Liu J; Tian T; Liu X; Cui Z
J Immunol Res; 2022; 2022():6051092. PubMed ID: 35915658
[TBL] [Abstract][Full Text] [Related]
37. Tumor Microenvironment CD8 T and Treg Cells-related Genes Signature Distinguishes Distinct Prognosis and Targeted Therapies Response in Endometrial Cancer.
Liu X; Feng D; Wang W; Liang J; Yu H; Ling B
J Immunother; 2023 Jun; 46(5):178-191. PubMed ID: 37098928
[TBL] [Abstract][Full Text] [Related]
38. Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer.
Weijiao Y; Fuchun L; Mengjie C; Xiaoqing Q; Hao L; Yuan L; Desheng Y
Aging (Albany NY); 2021 Jun; 13(12):16713-16732. PubMed ID: 34170849
[TBL] [Abstract][Full Text] [Related]
39. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
40. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
